| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.1 |